Kiniksa Pharmaceuticals - KNSA Bozor qiymati
GURU.Markets platformasidagi Kiniksa Pharmaceuticals (KNSA) uchun ushbu kunlik narxlar grafigi, unda indikator 4.68 qiymatida turibdi, noyob kasalliklar uchun unikal davolash usullarini ishlab chiqayotgan yetakchi olimlarning fidoyiligi bilan qo'llab-quvvatlanmoqda. Aksiyalar narxining ko'tarilishi asosiy mahsulotning bozorga muvaffaqiyatli chiqarilishi va yangi bemorlar oqimi bilan bog'liqdir. Biznes barqarorligi ixtisoslashtirilgan markazlar bilan yaqin aloqalar orqali kafolatlanadi, bu esa bemorlar uchun terapiyani o'zgartirishni deyarli imkonsiz qiladi.
Kiniksa Pharmaceuticals (KNSA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- bozor narxi va tahlilchilarning maqsadli narxlari:
- emitentning bozor qiymati haqida ma'lumotlar:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati Kiniksa Pharmaceuticals|KNSA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati kiniksa.com|KNSA - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Kiniksa Pharmaceuticals, Ltd.|KNSA - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Kiniksa|Tezkor likvidlik koeffitsiyenti kiniksa.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
KNSA - Sof foyda|Kelajakdagi foyda Kiniksa Pharmaceuticals|KNSA - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori kiniksa.com|KNSA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Kiniksa Pharmaceuticals, Ltd.|KNSA - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Kiniksa|KNSA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi kiniksa.com|KNSA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Kiniksa Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:KNSA (Kiniksa Pharmaceuticals Ltd)
Kiniksa Pharmaceuticals (KNSA) ARCALYST vositasida perikarditni davolashda monopoliya maqomini saqlab qolmoqda, bu esa sezilarli narx belgilash imkoniyatini yaratadi, garchi bozor kapitalizatsiyasining tebranishlari asosiy operatsion xatarlardan signal berishi mumkin bo'lsa-da. Kompaniyaning bozor baholash tendentsiyalarini tahlil qilish orqali investor barcha aksiyalarning umumiy bozor qiymatini aniqlaydi, bu esa aktivning fundamental ishonchliligini tekshirish uchun joriy biznes ko'lamini tarixiy cho'qqilar bilan solishtirish imkonini beradi.
Muhim raqobatchilar
Bozor qiymati Argenx ARGX|BNTX: Bozor kapitallashuvi|ABVX: Bozor bahosi|ADMA Biologics (ADMA) - Bozor bahosi|PTGX (Protagonist Therapeutics Inc) - Bozor bahosi|IMVT: Bozor qiymati|Bozor qiymati Grifols|Adaptive Biotechnologies Corp - Bozor bahosi|Bozor kapitallashuvi CLDX|AUPH (Aurinia Pharmaceuticals) - Bozor qiymati|Bozor kapitallashuvi BCRX (biocryst.com)|Bozor kapitallashuvi Vera Therapeutics Inc VERA|DNTH - Bozor qiymati|Bozor qiymati PHVS (Pharvaris Pharma)|AbCellera Corp (ABCL) - Bozor qiymati|Bozor bahosi Tourmaline Bio, Inc.|PGEN (precigen.com) - Bozor kapitallashuvi|Bozor kapitallashuvi Pharming|Bozor bahosi NKTR (Nektar)|Bozor kapitallashuvi Upstream Pharma|Bozor kapitallashuvi ZBIO (zenasbio.com)|Bozor kapitallashuvi immunome.com (IMNM)|GOSS - Bozor qiymati|KalVista Pharma (KALV) - Bozor bahosi|Septerna Pharma (SEPN) - Bozor qiymati|Bozor bahosi Pieris Pharmaceuticals|Bozor bahosi SVRA|Bozor kapitallashuvi rigel.com|Bozor qiymati AnaptysBio Corp (ANAB)|Astria Therapeutics, Inc. - Bozor kapitallashuvi|Bozor kapitallashuvi ENGN (engene.com)|RAPT Therapeutics Inc. (RAPT) - Bozor qiymati|Aerovate Therapeutics Inc - Bozor kapitallashuvi|ACRS - Bozor kapitallashuvi|KYTX (Kyverna Therapeutics, Inc) - Bozor bahosi|TLSA - Bozor kapitallashuvi|CABA (Cabaletta Bio, Inc) - Bozor kapitallashuvi|Bozor kapitallashuvi VTYX (Ventyx Biosciences)|Bozor qiymati Theratechnologies Inc. (THTX)|Bozor qiymati AVTX (avalotx.com)|Bozor qiymati Eledon Pharmaceuticals, Inc ELDN|Bozor kapitallashuvi Agenus, Inc. AGEN|CLYM: Bozor bahosi|ZURA: Bozor qiymati|ATYR: Bozor kapitallashuvi|Bozor qiymati Adagene Inc (ADAG)|IMA (Ikena Oncology) - Bozor kapitallashuvi|Bozor kapitallashuvi Shattuck Labs|Bozor kapitallashuvi EQ|Bozor qiymati CNTB (Connect Biopharma Holdings Limited)|Bozor qiymati immunic-therapeutics.com IMUX|Bozor qiymati ATRA (Atara Biotherapeutics Inc)|IFRX: Bozor bahosi|X4 Pharmaceuticals, Inc. (XFOR) - Bozor bahosi|ACET: Bozor kapitallashuvi|CELU - Bozor kapitallashuvi|Bozor qiymati INmune Bio|Bozor qiymati Barinthus Biotherapeutics plc BRNS|Bozor kapitallashuvi KZR|SABS - Bozor qiymati|Akari Therapeutics Plc - Bozor bahosi|enlivex.com (ENLV) - Bozor qiymati|QTTB - Bozor qiymati|Bozor kapitallashuvi GeoVax Labs, Inc. GOVX|EDSA: Bozor kapitallashuvi|iBio Inc - Bozor qiymati|CARM (Carisma Therapeutics Inc.) - Bozor kapitallashuvi|XTL Biopharmaceuticals, Ltd. (XTLB) - Bozor kapitallashuvi|Bozor kapitallashuvi BOLT|HCWB (HCW Biologics) - Bozor qiymati|Bozor kapitallashuvi APVO (Aptevo Therapeutics, Inc.)|Bozor qiymati AIM|ADTX: Bozor bahosi|Bozor qiymati GRI (GRI Bio Corp)|XRTX: Bozor kapitallashuvi|Bozor kapitallashuvi HIND|Bozor qiymati Revelation Biosciences, Inc.|Bozor kapitallashuvi INDP (Indaptus Therapeutics, Inc.)|Bozor kapitallashuvi SCNI|CALI (CalciMedica Inc) - Bozor qiymati|Bozor kapitallashuvi AFMD (Affimed NV)|ALLK - Bozor bahosi|HOOKIPA Pharma Inc. - Bozor kapitallashuvi|Bozor qiymati IGMS (igmbio.com)|iTeos Pharma (ITOS) - Bozor qiymati|Ocean Bio - Bozor qiymati|TCBP (TC BioPharm (Holdings) Plc) - Bozor kapitallashuvi|Bozor kapitallashuvi Third Harmonic Bio, Inc.
